Sol Capital Management CO Gsk PLC Transaction History

Sol Capital Management CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$38.11 - $42.99 $188,987 - $213,187	-4,959 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$37.87 - $43.58 $187,797 - $216,113	4,959 New	4,959 $202,000
Q1 2020 Apr 22, 2020	SELL	$32.47 - $48.83 $161,018 - $242,147	-4,959 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$42.0 - $48.25 $6,762 - $7,768	161 Added 3.36%	4,959 $233,000
Q3 2019 Oct 21, 2019	BUY	$40.46 - $43.52 $194,127 - $208,808	4,798 New	4,798 $205,000

Q2 2019 Jul 17, 2019	SELL	$39.4 - $42.7 $189,041 - $204,874	-4,798 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$38.57 - $42.69 $38,570 - $42,690	-1,000 Reduced 17.25%	4,798 $201,000
Q4 2018 Jan 25, 2019	SELL	$37.8 - $42.69 $16,064 - $18,143	-425 Reduced 6.83%	5,798 $222,000
Q3 2018 Oct 29, 2018	SELL	$39.75 - $42.69 $24,645 - $26,467	-620 Reduced 9.06%	6,223 $250,000
Q2 2018 Jul 11, 2018	SELL	$39.61 - $42.76 $1,980 - $2,138	-50 Reduced 0.73%	6,843 $276,000
Q1 2018 Apr 25, 2018	SELL	$36.18 - $40.15 $9,045 - $10,037	-250 Reduced 3.5%	6,893 $269,000
Q4 2017 Jan 31, 2018	SELL	$35.34 - $41.9 $79,515 - $94,275	-2,250 Reduced 23.95%	7,143 $253,000
Q3 2017 Oct 27, 2017	BUY	$39.44 - $41.55 $370,459 - $390,279	9,393	9,393 $381,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $77.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

Stay updated on Sol Capital Management CO with notifications on news.